Hypersensitivity syndrome during medication with carbamazepine;Hypersensitivitätssyndrom nach einnahme von carbamazepin

Aktuelle Dermatologie

Volumn 32, Issue 4, 2006, Pages 130-135

  Wagner, C ^a  

^a Klinikum Bremerhaven Reinkenheide   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CARBAMAZEPINE; STEROID;

ADULT; ARTICLE; CASE REPORT; DRUG ERUPTION; DRUG HYPERSENSITIVITY; ENDOGENOUS DEPRESSION; EOSINOPHIL; ERYTHEMA; FEMALE; HUMAN; LYMPHADENOPATHY; PROGNOSIS; SPLENOMEGALY;

EID: 33646271814     PISSN: 03402541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-925066     Document Type: Article

References (48)

1. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rush with Eosinophilia and Systemic Symptoms: DRESS). Semin Cut Med Surg 1996; 15: 250-257
2. Uetrecht JP. The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions. Drug metabolism reviews 1992; 24: 299-366
3. Coleman JW. Allergic reactions to drugs: current concepts and problems. Clin Exp Allergy 1990; 20: 79-85
4. Bessmertny O, Hatton RC, Gonzalez-Peralta RP. Antiepileptic hypersensitivity syndrome in children. Ann Pharmacother 2001; 35: 533-538
5. Verrotti A, Feliciani C, Morresi S et al. Carbamazepine-induced hypersensitivity syndrome in a child with epilepsy. Int J Immunpathol Pharmacol 2000; 13: 49-53
6. Bork K. Arzneimittelnebenwirkungen an der Haut. 2. Aufl. Stuttgart, New York: Schatthauer, 1999
7. Wozel G. Dapson. 1. Aufl. Stuttgart, New York: Thieme, 1996
8. Parker WA, Shearer CA. Phenytoin hepatotoxicity. A case report and review. Neurology 1979; 29: 175-179
9. Wolkenstein P, Revuz J. Drug-induced severe skin reactions. Incidence, management and prevention. Drug Safety 1995; 13: 56-68
10. Brockmeyer NH. Deutsch-Österreichische Leitlinien zur antiretroviralen Therapie der HIV-Infektion. Dtsch Med Wochenschr 2003; 128: 7-18
11. Kaufmann D, Pichler W, Beer J. Severe episode of high fever with rash, lymphadenopathy, neutropenia, and eosinophilia after minocycline therapy for acne. Arch Intern Med 1994; 154: 1983-1984
12. Knowles SR, Shapiro L, Shear NH. Serious adverse reactions induced bei minocycline. Arch Dermatol 1996; 132: 934-939
13. Richter G, Horn K, Wozel G et al. Carbamazepin-Hypersensitivitäts- syndrom. Z Klin Med 1986; 41: 1803-1804
14. Sillanpää M. Carbamazepine: pharmacology and clinical uses. Acta Neurol Scand 1981; 64 (suppl 88): 1-202
15. Zakrzewska JM, Ivanyi L. In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10,11-epoxid and oxcarbamazepine in the diagnosis of drug-induced hypersensitivity. J Allergy Clin Immunol 1988; 82: 110-115
16. Schnyder B, Zanni MP, Pichler WJ. Medikamenteninduzierte Hypersensitivitätssyndrome. Schweiz Med Wschr 1997; 127: 355-359
17. Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamezepine, or sodium valproate. A record linkage study. Neurology 1997; 49: 542-546
18. Elstner S, Sperling W. Das Carbamazepin-Hypersensitivitäts-Syndrom. Fortschr Neurol Psychiat 2000; 68: 188-192
19. Gall H, Merk H, Scherb W et al. Antikonvulsiva-Hypersensitivitäts- Syndrom auf Carbamazepin. Hautarzt 1994; 45: 494-498
20. Zeller A, Schaub N, Steffen I et al. Drug hypersensitivity syndrome to carbamazepine and human herpes virus 6 infection. Infection 2001; 31: 254-256
21. Kleier RS, Breneman DL, Boiko S. Generalized pustulation of an anticonvulsant hypersensitivity syndrome. Arch Dermatol 1991; 127: 1361-1364
22. Rütter A, Kalden H, Bonsmann G et al. Anticonvulsiva- Hypersensitivitäts-Syndrom. H u G 1998; 73: 741-744
23. Ronsdorf A, Schlienger RG, Haefeli W et al. Antikonvulsiva Hypersensitivitäts-Syndrom. Schweiz Rundsch Med Prax 1999; 88: 1660-1666
24. Bastuji-Garin S, Rzany B, Stern RS et al. Clinical classifications of cases of toxic epidermal necrolysis, Steven-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129: 92-96
25. Schreiber MM, McGegor JG. Peudolymphoma syndrome. A sensitivity to anticonvulsant drugs. Arch Dermatol 1968; 97: 297-326
26. Bonnetblanc JM. Drug hypersensitivity syndrome. Dermatology 1993; 187: 84-87
27. Chang D, Shear N. Cutaneous reactions to anticonvulsants. Sem Neurol 1992; 12: 329-337
28. Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med 1995; 155: 2285-2290
29. Haruda R. Phenytoin hypersensitivity: 38 cases. Neurology 1979; 29: 1480-1485
30. Powers NG, Carson NH. Idiosyncratic reactions to phenytoin. Clin Pediatr 1987; 25: 120-124
31. Flowers FP, Aranjo OE, Hamm KA. Phenytoin hypersensitivity syndrome. J Emerg Med 1987; 5: 103-108
32. Gupta A, Eggo MC, Uetrecht JP et al. Drug-induced hypothyroidism: The thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides. Clin Pharmacol Ther 1992; 51: 56-67
33. Handfield-Jones SE, Jenkins RE, Whittaker SJ et al. The anticonvulsant hypersensitivity syndrome. Br J Dermatol 1993; 129: 175-177
34. Ray-Chaudhuri K, Pye IF, Boggeld M. Hypersensitivity to carbamazepine presenting with a leukemoid reaction, eosinophilia, erythroderma, and renale failure. Neurology 1989; 39: 436-438
35. Stephan W, Parks R, Tempest B. Acute hypersensitivity pneumonitis associated with carbamazepine therapy. Chest 1978; 74: 463-464
36. Taliercio C, Olney B, Lie J. Myocarditis related to drug hypersensitivity. Mayo Clin Proc 1985; 60: 463-468
37. Braithwaite RF. A fatal case of agranulocytosis associated with "Tridione" therapy. Br Med J 1948; 1: 14
38. Spielberg SP, Gordon GB, Blake DA et al. Predisposition to phenytoin hepatotoxicity assessed in vitro. N Engl J Med 1981; 305: 722-727
39. Leeder JS. Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs. Epilepsia 1998; 39: 8-16
40. Riley R, Smith G, Wolf C et al. Human anti-endoplasmic reticulum autoantibodies produced in aromatic recognice rodent. CYP3A proteins and a similary regulated human P450 enzyme. Biochem Biophys Res Commun 1993; 191: 32-40
41. Aihara Y, Ito SI, Kobayashi Y et al. Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactiviation of human herpesvirus 6 demonstrated by real-time quantitative polymerase chain reaction. Br J Dermatol 2003; 149: 165-169
42. Hara H, Kobayashi M, Yokoyama A et al. Drug-induced hypersensivitity syndrome due to carbamazepine associated with reactivation of human herpesvirus 7. Dermatology 2005; 211: 159-161
43. Hashimoto K, Yasukawa M. Tohyama M. Human herpesvirus 6 and drug allergy. Curr Opin Allergy Clin Immunol 2003; 3: 255-260
44. Yates P, Stockdill G, McIntyre M. Hypersensitivity to carbamazepine presenting as pseudolymphoma. J Clin Pathol 1986; 39: 1224-1228
45. Houwerzijl J, de Gast G, Nato JP et al. Lymphocyte-stimulation tests and patch tests in carbamazepine hypersensitivity. Clin Exp Immunol 1977;29:272-277
46. Hyson C, Sadler M. Cross sensitivity of skin rashes with antiepileptic drugs. Can J Neurol 1997; 24: 245-249
47. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. J Clin Invest 1988; 82: 1826-1832
48. Mutschier E. Mutschier Arzneimittelwirkungen. 8. Aufl. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 2002